Spravato

FDA allows standalone use of nasal spray antidepressant Spravato (esketamine) : Shots

January 21, 2025

Spravato, the brand name for esketamine, has a newly approved indication for treatment-resistant depression. tadamichi/Getty Images/iStockphoto/iStockphoto hide caption toggle caption…

Spravato

FDA allows standalone use of nasal spray antidepressant Spravato (esketamine) : Shots

Oscar Viewing Party Essentials: Movie-Themed Decorations, 2025 Ballot

College basketball scores, winners and losers: Kansas, Alabama bounce back with big wins after bad losses

What Sets the SAG Awards Apart From the Rest

Who’s afraid of the big, bad sabbatical?

Zachary Levi in a Feel-Good Autism Drama

Oscar Viewing Party Essentials: Movie-Themed Decorations, 2025 Ballot

1000-Lb. Sisters’ Tammy Slaton Claps Back on Selfies Amid Weight Loss

Well, That Was Fast! Prince William Has Already Shaved Off The Beard!

RB Kyren Williams will return punts for Los Angeles Rams

Armie Hammer Says He’s Selling His Truck, Can’t Afford Gas Guzzler

Brittany Cartwright Once Said EXACTLY What Would Make Her Divorce Jax Taylor! This Is So Telling!